Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Carrillo

Showing results (101-110 of 522) with videos related to

Pageof 53
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1995
Ciprofloxacin for the treatment of cholera: a randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adultsE Gotuzzo, C Seas, J Echevarría, et al.
Annals of the New York Academy of Sciences|June 15, 1996
Upregulation of antioxidant enzyme activities by deprenyl. Implications for life span extensionK Kitani, K Miyasaka, S Kanai, et al.
Canadian Journal of Physiology and Pharmacology|February 1, 1990
Possible role of blood insulin levels on glutathione S-transferase activities from different tissues of male ratsC E Carnovale, J A Monti, V A Catania, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|December 12, 2013
Comparison of the spectrum of radiologic and clinical manifestations of pulmonary disease caused by Mycobacterium avium complex and Mycobacterium xenopiMaria C Carrillo, Demetris Patsios, Ute Wagnetz, et al.
Biogerontology|February 8, 2006
Dose-dependency of life span prolongation of F344/DuCrj rats injected with (-)deprenylK Kitani, S Kanai, K Miyasaka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1995
Efficacy and tolerability of ciprofloxacin prophylaxis in adult household contacts of patients with choleraJ Echevarría, C Seas, C Carrillo, et al.
Vaccine|January 1, 1992
Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in SpainM González, M G Mateu, M A Martínez, et al.
Frontiers in Neurology|April 1, 2021
Expanding Representation of Low and Middle Income Countries in Global Dementia Research: Commentary From the Alzheimer's AssociationClaire Sexton, Heather M Snyder, Lakshmi Chandrasekaran, et al.
The Journal of General Virology|July 29, 1998
In vivo analysis of the stability and fitness of variants recovered from foot-and-mouth disease virus quasispeciesC Carrillo, M Borca, D M Moore, et al.
Regulatory Toxicology and Pharmacology : RTP|November 19, 2022
Lack of human-relevant adversity of MOSH retained in tissues: Analysis of adversity and implications for regulatory assessmentA L Isola, J C Carrillo, P Lemaire, et al.
Pageof 53

Showing results (101-110 of 522) with videos related to

Sort By:
Pageof 53
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1995
Ciprofloxacin for the treatment of cholera: a randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adultsE Gotuzzo, C Seas, J Echevarría, et al.
Annals of the New York Academy of Sciences|June 15, 1996
Upregulation of antioxidant enzyme activities by deprenyl. Implications for life span extensionK Kitani, K Miyasaka, S Kanai, et al.
Canadian Journal of Physiology and Pharmacology|February 1, 1990
Possible role of blood insulin levels on glutathione S-transferase activities from different tissues of male ratsC E Carnovale, J A Monti, V A Catania, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|December 12, 2013
Comparison of the spectrum of radiologic and clinical manifestations of pulmonary disease caused by Mycobacterium avium complex and Mycobacterium xenopiMaria C Carrillo, Demetris Patsios, Ute Wagnetz, et al.
Biogerontology|February 8, 2006
Dose-dependency of life span prolongation of F344/DuCrj rats injected with (-)deprenylK Kitani, S Kanai, K Miyasaka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1995
Efficacy and tolerability of ciprofloxacin prophylaxis in adult household contacts of patients with choleraJ Echevarría, C Seas, C Carrillo, et al.
Vaccine|January 1, 1992
Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in SpainM González, M G Mateu, M A Martínez, et al.
Frontiers in Neurology|April 1, 2021
Expanding Representation of Low and Middle Income Countries in Global Dementia Research: Commentary From the Alzheimer's AssociationClaire Sexton, Heather M Snyder, Lakshmi Chandrasekaran, et al.
The Journal of General Virology|July 29, 1998
In vivo analysis of the stability and fitness of variants recovered from foot-and-mouth disease virus quasispeciesC Carrillo, M Borca, D M Moore, et al.
Regulatory Toxicology and Pharmacology : RTP|November 19, 2022
Lack of human-relevant adversity of MOSH retained in tissues: Analysis of adversity and implications for regulatory assessmentA L Isola, J C Carrillo, P Lemaire, et al.
Pageof 53